comprehensive -WSS

comprehensive

author：Wikipedia 2025-10-03 00:39:05 - browse：5952

light shines behind Pfizer CEO Albert Bourla as he attends a ceremony in Greece — Pfizer CEO Albert Bourla was one of a few pharmaceutical executives who donated to a failed Senate campaign in New Jersey. Giannis Papanikos/AP

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

Administration infighting over the national stockpile

The health department’s preparedness office overseeing national stockpiles of emergency medical gear is trying to cement its Covid-era power — and meeting with congressional skepticism.

The Administration for Strategic Preparedness and Response has seen demands for protective gear and therapies rapidly expand between the Covid-19 pandemic, the 2022 mpox outbreak, and now the spread of avian flu among cows. But its management of the nation’s medical stockpile — and its efforts to replenish depleting stock — are under fresh scrutiny from lawmakers. In particular, Republicans want answers on the $850 million that Congress clawed back from ASPR’s budget, and on why that cash wasn’t spent if the stockpile needed it so badly, my co-author Sarah Owermohle reports.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： WHO calls for emergency meeting on new China virus, as cases spread

explore

WSS

Medicare has a new plan to address drug shortages

Primary care doctor shortage won't be solved by free med school tuition

Medicare has a new plan to address drug shortages

GSK’s asthma push continues as drug succeeds in Phase 3 trials

Sanofi seeks simpler, safer CRISPR sickle cell cure

FDA approves RSV monoclonal antibody for infants, toddlers

explore

comprehensive

Administration infighting over the national stockpile

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Wikipedia

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Google and Epic fight stronger regulation of AI in health care

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Startup Neumora takes a novel depression drug to Phase 3

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Doctors find melanoma drugs effective against rare brain cancer

Psychedelics group wrestles with new pharma identity

How Medicaid coverage policies for immigrants impact new moms

Cancer drug shortages should be causing more outrage

Deliver public health messages at the right time

entertainment

At Orexo, a ‘turning point’ for everything but digital health

Custom gene therapy hints at new path for rare disease treatments

Black vets could get higher VA benefits if race not used in lung test

Novel spinal cord stimulator treats paralysis without surgery

HHS's proposed rule does nothing to address the climate crisis

Sepsis can kill a child within hours. Here's how hospitals are fighting back

leisure time

hotspot

explore

knowledge